Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib

Saved in:
Bibliographic Details
Main Authors: Joensuu, Heikki (Author) , Hohenberger, Peter (Author)
Format: Article (Journal)
Language:English
Published: April 15, 2014
In: Cancer
Year: 2014, Volume: 120, Issue: 15, Pages: 2325–2333
ISSN:1097-0142
DOI:10.1002/cncr.28669
Online Access:Verlag, Volltext: http://dx.doi.org/10.1002/cncr.28669
Verlag, Volltext: http://dx.doi.org/10.1002/cncr.28669I
Get full text
Author Notes:Heikki Joensuu, MD; Mikael Eriksson, MD; Kirsten Sundby Hall, MD; Jörg T. Hartmann, MD; Daniel Pink, MD; Jochen Schütte, MD; Giuliano Ramadori, MD; Peter Hohenberger, MD; Justus Duyster, MD; Salah-Eddin Al-Batran, MD; Marcus Schlemmer, MD; Sebastian Bauer, MD; Eva Wardelmann, MD; Maarit Sarlomo-Rikala, MD; Bengt Nilsson, MD; Harri Sihto, PhD; Karla V. Ballman, PhD; Mika Leinonen, MSci; Ronald P. DeMatteo, MD; and Peter Reichardt, MD
Description
Item Description:Gesehen am: 07.12.2016
Physical Description:Online Resource
ISSN:1097-0142
DOI:10.1002/cncr.28669